S1402S,  Ribonucleoside-Vanadyl Complex (200 mM) - 10 ml

S1402S, Ribonucleoside-Vanadyl Complex (200 mM) - 10 ml

S1404S,  RNA Cap Struc Analog [m7G(5')ppp(5')G] - 25 A260 units

S1404S, RNA Cap Struc Analog [m7G(5')ppp(5')G] - 25 A260 units

S1404L, RNA Cap Struc Analog [m7G(5')ppp(5')G] - 125 A260 units

4.817,12 RON

Cap analogs are used for cotransciptional capping of in vitro transcribed RNA.

SKU
NEB_S1404L

Cap analogs are used for cotransciptional capping of in vitro transcribed RNA. For most RNAs, elimination of the cap structure causes a loss of stability, especially against exonuclease degradation, and a decrease in the formation of the initiation complex of mRNAs for protein synthesis. Certain prokaryotic mRNAs containing a 5´ terminal cap structure are translated as efficiently as or more efficiently than eukaryotic mRNAs in a eukaryotic cell-free protein synthesizing system. Also a cap requirement has been observed for splicing eukaryotic substrate RNAs.

Sequence
7mG(5´)ppp(5´)G

Mai multe informatii
Price 4.048,00 RON (preturile sunt fara TVA)
Description

Cap analogs are used for cotransciptional capping of in vitro transcribed RNA. For most RNAs, elimination of the cap structure causes a loss of stability, especially against exonuclease degradation, and a decrease in the formation of the initiation complex of mRNAs for protein synthesis. Certain prokaryotic mRNAs containing a 5´ terminal cap structure are translated as efficiently as or more efficiently than eukaryotic mRNAs in a eukaryotic cell-free protein synthesizing system. Also a cap requirement has been observed for splicing eukaryotic substrate RNAs.

Sequence
7mG(5´)ppp(5´)G